We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
WesBanco
WSBC
$3.79B
| $65K | ﹤0.01% |
3,194
-58,758
| -95% | -$1.29M |
|
1752
Alcon
ALC
$32B
| $64K | ﹤0.01% |
1,115
-15,120
| -93% | -$856K |
|
1753
Winnebago Industries
WGO
$767M
| $64K | ﹤0.01% |
+964
| New | +$49.2K |
|
1754
LCI Industries
LCII
$2.12B
| $63K | ﹤0.01% |
544
-61
| -10% | -$5.62K |
|
1755
Lattice Semiconductor
LSCC
$15.1B
| $63K | ﹤0.01% |
2,219
-214
| -9% | -$5K |
|
1756
Pentair
PNR
$9.01B
| $63K | ﹤0.01% |
+1,668
| New | +$58.7K |
|
1757
Columbus McKinnon
CMCO
$465M
| $60K | ﹤0.01% |
1,802
-393
| -18% | -$10.8K |
|
1758
IPG Photonics
IPGP
$3.27B
| $60K | ﹤0.01% |
370
+290
| +363% | +$41.3K |
|
1759
Arthur J. Gallagher & Co
AJG
$62.5B
| $59K | ﹤0.01% |
605
-204,171
| -100% | -$18.1M |
|
1760
Viatris
VTRS
$19.5B
| $59K | ﹤0.01% |
3,643
-971
| -21% | -$15.7K |
|
|
CTT
1761
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $59K | ﹤0.01% |
6,694
+1,830
| +38% | +$14.2K |
|
1762
CytomX Therapeutics
CTMX
$602M
| $57K | ﹤0.01% |
+6,819
| New | +$63.3K |
|
1763
John B. Sanfilippo & Son
JBSS
$802M
| $57K | ﹤0.01% |
669
+28
| +4% | +$2.38K |
|
1764
Tapestry
TPR
$23.5B
| $56K | ﹤0.01% |
4,182
-14,815
| -78% | -$210K |
|
|
EPZM
1765
DELISTED
Epizyme, Inc
EPZM
| $56K | ﹤0.01% |
3,457
-99,658
| -97% | -$1.74M |
|
1766
Whirlpool
WHR
$2.11B
| $55K | ﹤0.01% |
+423
| New | +$48.4K |
|
1767
Perrigo
PRGO
$1.88B
| $54K | ﹤0.01% |
972
-178
| -15% | -$9.38K |
|
1768
Southern Missouri Bancorp
SMBC
$799M
| $54K | ﹤0.01% |
2,218
+27
| +1% | +$624 |
|
|
IMGN
1769
DELISTED
Immunogen Inc
IMGN
| $54K | ﹤0.01% |
11,592
-234,409
| -95% | -$997K |
|
|
JBTM
1770
JBT Marel
JBTM
$5.78B
| $53K | ﹤0.01% |
614
+90
| +17% | +$6.98K |
|
|
NGM
1771
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $53K | ﹤0.01% |
2,681
-625
| -19% | -$11.9K |
|
1772
DXP Enterprises
DXPE
$2.85B
| $52K | ﹤0.01% |
2,630
+930
| +55% | +$15K |
|
1773
Insight Enterprises
NSIT
$4.85B
| $51K | ﹤0.01% |
1,035
-55,459
| -98% | -$2.73M |
|
|
OLP
1774
One Liberty Properties
OLP
$501M
| $51K | ﹤0.01% |
+2,887
| New | +$45.7K |
|
|
RPAI
1775
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $51K | ﹤0.01% |
6,988
-691
| -9% | -$3.98K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.